Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ciputra Development Tbk (CTRA) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Ciputra Development TbkTrade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Ciputra Development Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Ciputra Development Tbk trades at Rp595 (market cap 11.31T, 6.71M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: Ciputra Development Tbk and Tempo Scan Pacific Tbk. are close in size by market cap, and Ciputra Development Tbk is more actively traded (6.71M versus 235.2K). Which is the better fit depends on your goals.

CTRATSPC
Market Cap
11.31T12.58T
Volume
6.71M235.2K
Lot
67.06K2.35K
Turnover
4.02B649.94M
Average Price
598.922,763.37
Value
4.02B649.94M
Indicative Equilibrium Price
5952,780
Indicative Equilibrium Volume
7329

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CTRA
View details
TSPC
View details

About Ciputra Development Tbk

PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.

Read more on CTRA

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC